Viewing Study NCT00885820


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT00885820
Status: COMPLETED
Last Update Posted: 2014-09-18
First Post: 2009-04-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module